MentionFox
Home › funding signals › Galvanize Therapeutics, Inc.
Form D · on the record

Galvanize Therapeutics — $136.19M Form D filing, November 2026

Before you sell to, join or invest in Galvanize Therapeutics, Inc.

MentionFox check on Galvanize Therapeutics, Inc.: only 1 source on file so far (checked 19 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/galvanize-therapeutics-inc-form-d-000004

Check Galvanize Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Galvanize Therapeutics, Inc.?

Galvanize Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-18.

Galvanize Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 18, 2026. Galvanize Therapeutics, Inc. was formerly named Gala Therapeutics, Inc. The filing reports $136.19M sold. Its industry group is Biotechnology. It names Doug Godshall (Executive Officer, Director), Seth Harrison (Director), Antoine Papiernik (Director) (SEC Form D, November 18, 2026).

In its own words: “Galvanize Therapeutics designs pulsed electric field energy devices for the surgical ablation of soft tissue, engineered to work with the body's biology.” (galvanizetx.com, checked November 19, 2026)

Sell to companies like Galvanize Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Galvanize Therapeutics, Inc. raised on Nov 18. 137 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Linework USA INC.$1.2BAI and software
Linework USA INC.$326MAI and software
Pathos AI, Inc.$238MBiotech
Galvanize Therapeutics, Inc.$136MBiotech
Tractian Inc.$106MAI and software
Check one company free All companies that raised this week

Selling to Galvanize Therapeutics, Inc.? See who runs it and how to reach them, plus this week's 161 other newly funded companies.

Is this your company?

Key facts

Run the free check on Galvanize Therapeutics, Inc. →

Galvanize Therapeutics, Inc.

New Form D on file · 2026-11-18 · the record

$136.19M
raise on the record
D
filing
26
investors in
CALIFORNIA
based
Open the record →

What the record says

FilingForm D
Filed2026-11-18
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
BasedREDWOOD CITY, CALIFORNIA
CIK1659073
Accession0001659073-26-000004

Pitching, partnering or investing alongside them? See who really runs and owns Galvanize Therapeutics, Inc.

Free to see. No signup.

What do you want to do with Galvanize Therapeutics, Inc.?

Get the full cited report on Galvanize Therapeutics, Inc.

What the filing shows about Galvanize Therapeutics, Inc.

  • 26 investors had already put money in when it filed.
  • The filing names 9 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Galvanize Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look Galvanize Therapeutics, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Galvanize Therapeutics, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives Galvanize Therapeutics, Inc.'s address as 3200 Bridge Parkway, Redwood City, CA 94065.

What the filing says

  • Offered: $136,185,232. Sold: $136,185,232. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 26 had already invested. (filing)
  • Date of first sale: November 6, 2026. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • New money and converted: Of the $136.19M sold, $130M was new money and $6.19M came from securities that converted (5%), the filing says. (filing)
  • Securities that converted: the filing says “$129,999,994.96 new money; $6,185,237.68 conversion of debt” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Galvanize Therapeutics, Inc. See pricing

Is Galvanize Therapeutics, Inc. a real, registered company?

Galvanize Therapeutics, Inc. is a registered filer with the SEC (CIK 1659073) and has filed since 2025-09-11. 2 filings are on record, the latest on 2026-11-18.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Galvanize Therapeutics, Inc.?

Galvanize Therapeutics, Inc.'s Form D of 2026-11-18 names Doug Godshall, Seth Harrison, Antoine Papiernik and 6 more as its officers, directors or promoters.

How much has Galvanize Therapeutics, Inc. raised?

Its new offerings report $232.32M sold across 2 offerings, as its own filings state.

Filing history · 2 filings on this registrant
Form D · 2025-09-11 · $96.13MForm D · 2026-11-18 · $136.19M · this page 2025-09-11 2026-11-18

Each marker is one filing. The larger marker is the filing this page is about.

Biotechnology · by week
This raise, $136.19M, filed week of Nov 16

Trailing twelve months. 758 filings in Biotechnology, totalled by week. The dot is this raise, $136.19M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Galvanize Therapeutics, Inc.?

What the filing shows about Galvanize Therapeutics, Inc.

  • 26 investors had already put money in when it filed.
  • The filing names 9 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Galvanize Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Galvanize Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Galvanize Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Galvanize Therapeutics, Inc.: Raised $136.19M, Form D filed 2026-11-18
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/galvanize-therapeutics-inc-form-d-000004
Last updated 2026-11-19
Primary record: SEC filing 1 · SEC filing 2
Galvanize Therapeutics raised $136.19M — SEC Form D filing, November 2026. MentionFox, 2026-11-19. https://mentionfox.com/funding/galvanize-therapeutics-inc-form-d-000004